BCL2 and B-cell chronic lymphocytic leukemia: BTKi increase CLL dependence on BCL2 by downregulating the other key anti-apoptotic proteins MCL1 and BCL-XL which are known to contribute to primary sensitivity to Ven and secondary resistance [98].